SyntheX is a San Francisco-based biotechnology company that utilizes genetics and synthetic biology to develop innovative drug discovery engines. Their cutting-edge technology, including ToRPPIDO and ToRNeDO, enables the discovery of therapeutics for traditionally undruggable targets by targeting inaccessible mechanisms of action.
With a focus on oncology, SyntheX's internal programs aim to minimize clinical resistance pathways by modulating established targets in orthogonal ways, based on genetically validated targets and the concepts of oncogene addiction and synthetic lethality.
Generated from the website